Chris Pardue
Nashville, TNNPI 1841369675
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 91 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 22 manufacturers reported payments, led by AbbVie at 27.0% of the total. Reporting peaked in 2019 at $1,223 and has fallen 98.4% since, to $19 in 2022.
Across 91 payments — averaging $17.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$436
- Lilly USA, LLC$137
- Novartis$134
- Johnson & Johnson$132
- Sun Pharmaceutical Industries Inc.$120
- Merz North America, Inc.$84
- plus $570 from 16 others
What the payments were for
- Food & beverage$1,612100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 27 | $436 |
| Lilly USA, LLC | 7 | $137 |
| Novartis | 9 | $134 |
| Johnson & Johnson | 8 | $132 |
| Sun Pharmaceutical Industries Inc. | 6 | $120 |
| Merz North America, Inc. | 2 | $84 |
| EPI Health, LLC | 3 | $76 |
| Sanofi | 3 | $60 |
| UCB, Inc. | 3 | $59 |
| Pfizer | 3 | $45 |
| Genentech USA, Inc. | 3 | $45 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 3 | $44 |
| Biofrontera Inc. | 2 | $39 |
| Mylan Pharmaceuticals Inc. | 2 | $38 |
| Regeneron Healthcare Solutions, Inc. | 2 | $35 |
| Merck | 2 | $27 |
| Dermira, Inc. | 1 | $22 |
| Almirall LLC | 1 | $19 |
| Sandoz | 1 | $18 |
| Amgen | 1 | $16 |
| Taro Pharmaceuticals USA, Inc. | 1 | $15 |
| Galderma Laboratories, L.p. | 1 | $11 |
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.